Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-09 Tax Withholding(A) | 2024-10-02 2:15 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Wargacki Stephen Chief Science Officer | 19,505 | $4.88 | 261,414 (Direct) | View |
| 2024-05-10 Option Award | 2024-05-13 1:40 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Wargacki Stephen Chief Science Officer | 10,000 | $0 | 267,963 (Direct) | View |
| 2024-03-09 Tax Withholding | 2024-03-12 1:46 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Wargacki Stephen SVP, Research & Development | 12,956 | $4.88 | 257,963 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-11 10:34 am | N/A 2034-03-07 | Aquestive Therapeutics Inc. | AQST | Wargacki Stephen SVP, Research & Development | 168,750 | $0 | 327,169 (Direct) | View |
| 2023-03-10 Tax Withholding | 2024-03-11 10:34 am | N/A N/A | Aquestive Therapeutics Inc. | AQST | Wargacki Stephen SVP, Research & Development | 1,981 | $0.7937 | 327,169 (Direct) | View |
| 2023-08-09 Option Award | 2023-08-09 4:30 pm | N/A 2026-05-05 | Aquestive Therapeutics Inc. | AQST | Wargacki Stephen SVP, Research & Development | 67,500 | $0 | 67,500 (Direct) | View |
| 2023-05-05 Option Award | 2023-05-05 4:00 pm | N/A 2026-05-05 | Aquestive Therapeutics Inc. | AQST | Wargacki Stephen SVP, Research & Development | 67,500 | $0 | 67,500 (Direct) | View |
| 2023-03-09 Option Award | 2023-03-09 3:06 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Wargacki Stephen SVP, Research & Development | 135,000 | $0 | 161,956 (Direct) | View |
Ownership | 2023-01-11 4:05 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Wargacki Stephen SVP, Research & Development | 0 | $0 | 125,456 (Direct) | View |